FDA applicant
Neuronetics, Inc.
FDA records 15 decisions for Neuronetics, Inc. (Malvern, PA) from 2008 to 2024: 14 510(k) clearances and 1 De Novo grant. Most are in product codes OBP (Transcranial Magnetic Stimulator) and QCI (Transcranial Magnetic Stimulation System For…). Since 2016 its 510(k)s took a median of 88 days from receipt to decision, against 119 for FDA’s reviews in the same codes and years. Its devices cite 55 predicates, 53 of them its own earlier devices. 2 recalls are linked to its devices.
FDA’s records also spell it “Neuronetics”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Neuronetics, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2024
2026 so far, outlined.
Recalls per year
1in 2026
Class I Class II/III not classified
Planning a device like Neuronetics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report